Alpha 2.0
Login Register
» Articles » PMID: 17062698

The Activity of Sunitinib Against Gastrointestinal Stromal Tumor Seems to Be Distinct from Its Antiangiogenic Effects

Overview
Journal Clin Cancer Res
Specialty Oncology
Date 2006 Oct 26
PMID 17062698
Citations 10
Authors
Marco Seandel
Jinru Shia
Irina Linkov
Robert G Maki
Cristina R Antonescu
Jakob Dupont
Affiliations
Soon will be listed here.
Citing Articles

Role of Sam68 in Sunitinib induced renal cell carcinoma apoptosis.

Wu Z, Peng Y, Xiong L, Wang J, Li Z, Ning K Cancer Med. 2022; 11(19):3674-3686.

PMID: 35476809 PMC: 9554455. DOI: 10.1002/cam4.4743.

The pancreatic niche inhibits the effectiveness of sunitinib treatment of pancreatic cancer.

Martinez-Bosch N, Guerrero P, Moreno M, Jose A, Iglesias M, Munne-Collado J Oncotarget. 2016; 7(30):48265-48279.

PMID: 27374084 PMC: 5217016. DOI: 10.18632/oncotarget.10199.

Enhancement of nab-paclitaxel antitumor activity through addition of multitargeting antiangiogenic agents in experimental pancreatic cancer.

Awasthi N, Zhang C, Schwarz A, Hinz S, Schwarz M, Schwarz R Mol Cancer Ther. 2014; 13(5):1032-43.

PMID: 24608575 PMC: 4418522. DOI: 10.1158/1535-7163.MCT-13-0361.

Evaluation of poly-mechanistic antiangiogenic combinations to enhance cytotoxic therapy response in pancreatic cancer.

Awasthi N, Zhang C, Ruan W, Schwarz M, Schwarz R PLoS One. 2012; 7(6):e38477.

PMID: 22723862 PMC: 3377661. DOI: 10.1371/journal.pone.0038477.

Modulation of Akt/mTOR signaling overcomes sunitinib resistance in renal and prostate cancer cells.

Makhov P, Golovine K, Kutikov A, Teper E, Canter D, Simhan J Mol Cancer Ther. 2012; 11(7):1510-7.

PMID: 22532600 PMC: 3491642. DOI: 10.1158/1535-7163.MCT-11-0907.